Skip to main content

Fractyl Health, Inc.

GUTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001572616

In the last 90 days, Fractyl Health, Inc. insiders filed 1 open-market purchase and 0 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $56.2M in total; Maverick Capital is the only superinvestor holding it.

Key figures

Market capClose on Nov 9, 2026
$11.9M
Insider buysLast 90 days, $39.9K in total
1
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −6 vs. previous quarter
79
13F valueReported value at the end of Q2 2026
$56.2M
Superinvestors holdingAt the end of Q2 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$0
−100.0% year over year
Net income, FY2025
-$141.0M
No comparable prior period
Free cash flow, FY2025
-$90.9M
No comparable prior period
Revenue, Q2 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 15, 2026.

Short interest
265.3K
Shares sold short
Change
−1.89M
−87.7% vs. previous
Days to cover
1.21
At average daily volume

Superinvestors holding GUTS, Q2 2026

Go to the superinvestors tab

1 superinvestor reports holding Fractyl Health, Inc. on Form 13F. Percentages are the stock's share of each portfolio.

Maverick Capital

Lee Ainslie

<0.1%

Fractyl Health, Inc.'s share of the portfolio

Shares
3,974,806
Value
$3.16M

Latest insider trades

See all insider trades

Open-market purchases and sales by Fractyl Health, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 16, 2026 (view filing)4:05 PM ETSep 142 daysBradley WilliamDirectorPPurchase+64.5K$0.6185+$39.9K+76.2%149.1K after
Jun 15, 2026 (view filing)Jun 123 daysRoyan AjayDirectorPPurchase+23.0K$0.85+$19.6K+128.5%40.9K after
Jun 11, 2026 (view filing)Jun 101 dayBradley WilliamDirectorPPurchase+68.5K$0.73+$50.0K+424.7%84.6K after
Jun 11, 2026 (view filing)Jun 101 daySheffield IanDirectorPPurchase+35.0K$0.73+$25.6KNew position35.0K after
Jun 11, 2026 (view filing)Jun 101 dayRajagopalan HarithChief Executive OfficerPPurchase+25.0K$0.73+$18.3K+4.8%540.6K after
Jun 9, 2026 (view filing)Jun 81 daySmith Weber LaraChief Financial OfficerPPurchase+20.0K$0.69+$13.8KNew position20.0K after
Dec 8, 2025 (view filing)Dec 44 daysRajagopalan HarithChief Executive OfficerPPurchase+10.4K$1.92+$20.0K+2.1%501.7K after
Mar 18, 2025 (view filing)Mar 144 daysRoyan AjayDirector, 10% OwnerPPurchase+17.9K$1.28+$22.9KNew position17.9K after
Mar 18, 2025 (view filing)Mar 144 daysBarnes Kelly AnnDirectorPPurchase+31.0K$1.30+$40.3KNew position31.0K after
Mar 17, 2025 (view filing)Mar 134 daysSchulman Amy WDirectorPPurchase+8.55K$1.17+$10.0KNew position8.55K after

Top 10 13F holders, Q2 2026

See all 79 holders

The largest institutional positions in Fractyl Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding GUTS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC11,289,096$8.97M0.54%−2,075,423−15.5%Reduced
Catalio Capital Management, LP6,168,749$4.90M0.92%+676,883+12.3%Added
Vanguard Capital Management LLC6,096,926$4.84M0.00%+563,920+10.2%Added
Bank of America Corp6,034,147$4.79M0.00%+5,909,158+4,727.7%Added
Pale Fire Capital SE5,003,237$3.97M0.28%−917,808−15.5%Reduced
General Catalyst Group Management, LLC4,884,186$3.88M2.06%−70.0%Reduced
Deer Management Co. LLC4,770,901$3.79M0.47%00.0%Unchanged
Maverick Capital LtdSuperinvestorMaverick Capital3,974,806$3.16M0.03%00.0%Unchanged
M28 Capital Management LP1,856,117$1.47M3.13%00.0%Unchanged
BlackRock, Inc.1,801,060$1.43M0.00%−338,777−15.8%Reduced

Holders of 5% or more of GUTS

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fractyl Health, Inc..

Largest holders of GUTS from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Nantahala Capital Management, LLC13G/A9.99%16.1M shares0.00 ppfrom 9.99%Nov 14, 20252 filingsMay 15, 2026SEC
BVP VII Special Opportunity Fund LP13G9.90%4.77M sharesNewFeb 14, 20251 filingFeb 14, 2025SEC
Catalio Capital Management, LP13G5.60%736.8K sharesNewOct 13, 20261 filingOct 13, 2026SEC